cell death. We demonstrated (Y. Song, et.al. JACS, 2014, 136:5233-5236) that a multivalent polymer-peptide conjugate (mPPC) is a very potent inhibitor of Aβ aggregation. The polymer consists
life processes. In living organisms, these high-affinity carbohydrate-protein interactions occur through multivalent contacts, characterized by an enhancement of the affinity when the sugar ligand is presented…
uniformly convex and n-uniformly starlike functions which are analytic and multivalent with negative coefficients. The object of this paper is to study of the application of incomplete beta function ... uniformly convex…
shock syndrome or death. In response to these needs, we have developed a multivalent vaccine platform, based on the complex ad-vector vaccine platform (CAdVax), and have shown its efficacy ... without causing any…
including lung infections of cystic fibrosis patients, colitis, urethritis, conjunctivitis, otitis, endocarditis and periodontitis. Multivalency is ubiquitous in biological interactions, especially in…
sugar-protein interactions are intrinsically weak and this is overcome in nature by multivalent contacts, characterized by an enhancement of the affinity when sugar ligands are presented in a cluster ... Several…
complex disease aetiology can also be problematic. To address these issues the development of multivalent live viral vaccines has been undertaken using a bovine herpesvirus 1 infectious clone to deliver
which macromolecules penetrate the cytosolic space of cells. Herein, we report on how a multivalent cell penetrating peptide derived from the prototypical peptide TAT, mTAT, penetrates live cells by escaping
small heat shock protein, abundant larval transcript and tetraspanin) when combined as a multivalent fusion protein, the vaccine conferred over 95% protection against challenge infections in experimental animals…
produced in vitro after expression of MLV Gag protein, we have developed a multivalent vaccine that targets the gB protein as well as the gH protein, part of a pentameric
side effects. We demonstrate this new approach to drug design with the development of multivalent ligands for the treatment of neuropathic pain, the most ubiquitous disease in the world ... motor impairment. We also…
detectable stem-epitope directed antibodies upon initial exposure to antigen. We propose that antigen multivalency, a cornerstone of both vaccine design and viral architecture, imposes not only repetitive array ... stem…
detectable stem-epitope directed antibodies upon initial exposure to antigen. We propose that antigen multivalency, a cornerstone of both vaccine design and viral architecture, imposes not only repetitive array ... stem…
their anti-viral effects against HIV-1. Previously bowman et al. has shown that multivalent display of HIV inhibitors on gold nanoparticles (AuNPs) has lead to a substantial amount ... cell infection and p24 release…
others have suggested that for the detection and treatment of these diseases multivalent ligands can provide distinct advantages over monovalent drugs that are the mainstay of most current therapies. Advantages…
approaches to drug design and development. In particular it is possible to design multivalent ligands that can address 2 or more targets for the disease state, all in a single ... toxicities or development of tolerance…
cell death. We demonstrated (Y. Song, et.al. JACS, 2014, 136:5233-5236) that a multivalent polymer-peptide conjugate (mPPC) is a very potent inhibitor of Aβ aggregation. The polymer consists
glycodendrimers have stimulated increasing interests over the past decade. Among the large variety of multivalent scaffolds reported so far, our group is focusing on cyclopeptide-based glycoconjugates for diverse…
reported remarkable enhancement of the binding affinity by means of multivalent-type sugar substrates, so-called “sugar clustering effect”. In this paper, we describe the design, synthesis, and biological evaluation
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.